nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Gadofosveset trisodium—Pain—Vincristine—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Gadofosveset trisodium—Constipation—Vincristine—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Gadofosveset trisodium—Rash—Melphalan—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Gadofosveset trisodium—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Gadofosveset trisodium—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Gadofosveset trisodium—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Gadofosveset trisodium—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Gadofosveset trisodium—Nausea—Topotecan—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Gadofosveset trisodium—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Gadofosveset trisodium—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Gadofosveset trisodium—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000551	0.000551	CcSEcCtD
Gadofosveset trisodium—Infection—Etoposide—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Gadofosveset trisodium—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Gadofosveset trisodium—Nausea—Melphalan—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Gadofosveset trisodium—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000541	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000535	0.000535	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Gadofosveset trisodium—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000519	CcSEcCtD
Gadofosveset trisodium—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Gadofosveset trisodium—Pain—Cisplatin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Gadofosveset trisodium—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Gadofosveset trisodium—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Gadofosveset trisodium—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Gadofosveset trisodium—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Gadofosveset trisodium—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Gadofosveset trisodium—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Gadofosveset trisodium—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Gadofosveset trisodium—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Gadofosveset trisodium—Constipation—Etoposide—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Gadofosveset trisodium—Pain—Etoposide—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Gadofosveset trisodium—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Gadofosveset trisodium—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Gadofosveset trisodium—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Gadofosveset trisodium—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Gadofosveset trisodium—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Gadofosveset trisodium—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Gadofosveset trisodium—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Gadofosveset trisodium—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Gadofosveset trisodium—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Gadofosveset trisodium—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Gadofosveset trisodium—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Gadofosveset trisodium—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Gadofosveset trisodium—Rash—Vincristine—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Gadofosveset trisodium—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Gadofosveset trisodium—Headache—Vincristine—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Gadofosveset trisodium—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Gadofosveset trisodium—Nausea—Vincristine—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Gadofosveset trisodium—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Gadofosveset trisodium—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Gadofosveset trisodium—Chills—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Gadofosveset trisodium—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Gadofosveset trisodium—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Gadofosveset trisodium—Rash—Cisplatin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Gadofosveset trisodium—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Gadofosveset trisodium—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Gadofosveset trisodium—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Gadofosveset trisodium—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Gadofosveset trisodium—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Gadofosveset trisodium—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Gadofosveset trisodium—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Gadofosveset trisodium—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Gadofosveset trisodium—Rash—Etoposide—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Gadofosveset trisodium—Headache—Etoposide—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Gadofosveset trisodium—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Gadofosveset trisodium—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Gadofosveset trisodium—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Gadofosveset trisodium—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Gadofosveset trisodium—Cough—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Gadofosveset trisodium—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Gadofosveset trisodium—Nausea—Etoposide—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Gadofosveset trisodium—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Gadofosveset trisodium—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Gadofosveset trisodium—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Gadofosveset trisodium—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Gadofosveset trisodium—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Gadofosveset trisodium—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Gadofosveset trisodium—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Gadofosveset trisodium—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Gadofosveset trisodium—Infection—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Gadofosveset trisodium—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Gadofosveset trisodium—Shock—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Gadofosveset trisodium—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Gadofosveset trisodium—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Gadofosveset trisodium—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Gadofosveset trisodium—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Gadofosveset trisodium—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Gadofosveset trisodium—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Gadofosveset trisodium—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Gadofosveset trisodium—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Gadofosveset trisodium—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Gadofosveset trisodium—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000279	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Gadofosveset trisodium—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Gadofosveset trisodium—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Gadofosveset trisodium—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Gadofosveset trisodium—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Gadofosveset trisodium—Pain—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Gadofosveset trisodium—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Gadofosveset trisodium—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Gadofosveset trisodium—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Gadofosveset trisodium—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000228	CcSEcCtD
Gadofosveset trisodium—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadofosveset trisodium—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000222	CcSEcCtD
Gadofosveset trisodium—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Gadofosveset trisodium—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000205	CcSEcCtD
Gadofosveset trisodium—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000204	CcSEcCtD
Gadofosveset trisodium—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Gadofosveset trisodium—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000196	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Gadofosveset trisodium—Rash—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Gadofosveset trisodium—Headache—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Gadofosveset trisodium—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Gadofosveset trisodium—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000183	CcSEcCtD
Gadofosveset trisodium—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
Gadofosveset trisodium—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Gadofosveset trisodium—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Gadofosveset trisodium—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00017	CcSEcCtD
